Medical Innovation and Racial Health Disparities: Evidence from a Breakthrough Treatment
Working Paper 35210
DOI 10.3386/w35210
Issue Date
Revision Date
Whether medical innovation affects racial health disparities remains an open question. We explore the effect of surfactant replacement therapy (SRT), a breakthrough treatment for premature infants with respiratory disorders, on the Black-White neonatal mortality gap. Using non-respiratory mortality as a counterfactual outcome, we find that both Blacks and Whites benefited from the introduction of SRT in 1989, but White neonates experienced larger reductions in mortality. By 1993, SRT had reduced respiratory-related mortality among White neonates by 46 percent, compared to 30 percent for Black neonates. Neither socioeconomic status nor distance to the nearest neonatal intensive care unit explain these results.
-
-
Copy CitationD. Mark Anderson, Kerwin Kofi Charles, and Daniel I. Rees, "Medical Innovation and Racial Health Disparities: Evidence from a Breakthrough Treatment," NBER Working Paper 35210 (2026), https://doi.org/10.3386/w35210.Download Citation
-